Clinical trial Recruiting at 1 site Observational

Serum Fetuin‑A and COMP levels in knee osteoarthritis

Official title: The Relationship Between Clinical and Radiographic Severity of Knee Osteoarthritis and Serum Fetuin-A and COMP Levels: A Controlled Cross-Sectional Study

Run by Antalya Training and Research Hospital · NCT07706569 · Data updated 2026-11-12

This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.

More Knee Osteoarthritis trials

Quick facts

Study typeObservational
SexAll
Enrollment180 (estimated)
SponsorAntalya Training and Research Hospital
Government
Locations1 site (Antalya)
StatusRecruiting
StartedApril 1, 2026
Main results expectedAugust 30, 2026
Study endsDecember 30, 2026
Registry record updatedJuly 15, 2026
Trial IDNCT07706569 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with knee osteoarthritis who meet ACR criteria and are graded 2–4 on the Kellgren‑Lawrence scale.

Probably not a fit

Individuals without knee OA or with non‑knee inflammatory conditions may not benefit from this biomarker analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares serum biomarkers Fetuin‑A and COMP with clinical and radiographic severity of knee osteoarthritis. A total of 180 participants include 120 patients with Kellgren‑Lawrence grade 2–4 OA and 60 age‑ and sex‑matched healthy controls. Participants will undergo radiographs, clinical and functional assessments, and biomarker measurements to explore associations between biomarker levels and disease severity. The goal is to see if these biomarkers help reflect disease state and progression. Interventions are not used; the study is observational in design.

Why it matters

Potential benefit: If successful, Fetuin‑A and COMP could become part of a blood test to help assess OA severity and monitor progression.

How similar studies have gone: Previous research has shown associations between these biomarkers and OA features, but the utility for routine clinical assessment remains under investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Diagnosis of knee osteoarthritis according to ACR (American College of Rheumatology) criteria. Knee osteoarthritis classified as Grade 2, 3, or 4 according to Kellgren-Lawrence (K-L) grading. Volunteering to participate and providing signed informed consent.

Exclusion Criteria:

* Secondary post-traumatic knee osteoarthritis, history of major knee injury or joint infection. Signs of acute joint inflammation (swelling, heat increase, erythema). History of knee surgery (open or arthroscopic). Systemic inflammatory or autoimmune diseases. History of malignancy. Advanced renal or hepatic disease. Diagnosis of Diabetes Mellitus. Current use of systemic corticosteroids. Symptomatic osteoarthritis in other major joints (hip, hand, ankle, spine). Active systemic infection (fever ≥ 38, cough, diarrhea, dysuria, leukocytosis, or elevated CRP).

Where it's running

  • S.B.U. Antalya Training and Research Hospital, Department of Physical Medicine and Rehabilitation
    Antalya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.